Загрузка...
Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies
Intravenous immunoglobulin (IVIG) is a potential therapy for chronic inflammatory demyelinating polyneuropathy (CIDP). To investigate the efficacy and safety of the IVIG IgPro10 (Privigen) for treatment of CIDP, results from Privigen Impact on Mobility and Autonomy (PRIMA), a prospective, open‐label...
Сохранить в:
| Опубликовано в: : | J Peripher Nerv Syst |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Wiley Periodicals, Inc.
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6594229/ https://ncbi.nlm.nih.gov/pubmed/30672091 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jns.12302 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|